AXA Equitable Holdings, Inc. – Trademark Portfolio

Entity Type: 03

AXA Equitable Holdings, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 19 filings in this category. Currently, 8 trademarks are registered. Notable registered marks include EQUITABLE, EQUITABLE ADVISORS, EQUITABLE HOLDINGS, EQUITABLE EXCELLENCE, and EQUITABLE EXCELLENCE SCHOLARSHIP. The owner is based in New York, NY.

1290 Avenue of the Americas

New York, NY 10104

19 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AXA Equitable Holdings, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (19 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does AXA Equitable Holdings, Inc. have?

AXA Equitable Holdings, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 8 registered, 11 abandoned.

What trademark classes does AXA Equitable Holdings, Inc. file in?

AXA Equitable Holdings, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are AXA Equitable Holdings, Inc.'s most well-known trademarks?

AXA Equitable Holdings, Inc.'s registered trademark portfolio includes well-known marks such as EQUITABLE, EQUITABLE ADVISORS, EQUITABLE HOLDINGS, EQUITABLE EXCELLENCE, and EQUITABLE EXCELLENCE SCHOLARSHIP. These are among 8 currently registered trademarks in the portfolio.

What is AXA Equitable Holdings, Inc.'s trademark registration success rate?

AXA Equitable Holdings, Inc. has a 42% trademark registration rate, with 8 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.